CLOVER HEALTH INVESTMENTS, CORP. /DE CEO Jamie L. Reynoso sold 9,273 shares at $4.78 per share on 2026-09-15. Reynoso owned 2,805,367 shares afterward, and the transaction represented about 0.3% of the prior holding, giving investors a precise view of the reported ownership change.
Key Highlights
- Jamie L. Reynoso owned 2,805,367 shares following the transaction.
- SEC transaction code S identifies the transaction as an open-market sale.
- Jamie L. Reynoso sold 9,273 CLOVER HEALTH INVESTMENTS shares.
CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ: CLOV) recorded a sale of 9,273 shares by Jamie L. Reynoso at $4.78 per share. The transaction was dated 15 September 2026. The transaction carries SEC code S. That code denotes an open-market sale.
Reported Post-Transaction Ownership
Reynoso owned 2,805,367 shares after the transaction. The sale represented about 0.3% of Reynoso’s prior shares holding. The reported percentage is measured against the shares held before the transaction.
FAQs
Q: How many CLOVER HEALTH shares did Jamie Reynoso sell?
A: Jamie L. Reynoso sold 9,273 CLOVER HEALTH INVESTMENTS shares. The transaction price was $4.78 per share, and it was dated 15 September 2026.
Q: How many shares did Jamie Reynoso own after the CLOV transaction?
A: After the transaction, Jamie L. Reynoso owned 2,805,367 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE. Reynoso is identified as CEO, Medicare Advantage at the company.
Q: What does transaction code S mean for CLOVER HEALTH?
A: SEC transaction code S identifies an open-market sale. The reported CLOVER HEALTH transaction involved 9,273 shares sold at $4.78 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.